ChemoMetec Income Statement

Financials in millions DKK. Fiscal year is July - June.

Millions DKK. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	493.12	495.57	407.35	442.27	427.16	281.13
Revenue Growth (YoY)	7.31%	21.66%	-7.90%	3.54%	51.95%	31.31%
Cost of Revenue	21.98	30.06	40.28	32.9	44.14	27.78
Gross Profit	471.14	465.51	367.6	411.5	384.25	253.34
Selling, General & Admin	212.12	207.46	181.42	160.47	161.36	117.71
Depreciation & Amortization Expenses	27.94	21.53	17.21	20.47	20.04	19.61
Total Operating Expenses	240.06	228.99	198.63	180.94	181.4	137.32
Operating Income	231.08	236.52	168.97	230.56	202.85	116.02
Interest Income	0.69	5.9	8.9	2.52	1.88	0.92
Interest Expense	-3.11	-2.4	-1.28	-2.72	-1.52	-4.21
Total Non-Operating Income (Expense)	-2.43	3.5	7.62	-0.2	0.37	-3.29
Pretax Income	228.65	240.01	176.59	230.36	203.22	112.73
Provision for Income Taxes	51.62	53.61	40.3	51.69	43.75	24.38
Net Income	177.03	186.41	136.28	178.67	159.47	88.35
Net Income to Common	177.03	186.41	136.28	178.67	159.47	88.35
Net Income Growth	4.70%	36.78%	-23.72%	12.04%	80.49%	49.34%
Shares Outstanding (Basic)	17	17	17	17	17	17
Shares Outstanding (Diluted)	17	17	17	17	17	17
Shares Change (YoY)	0.07%	-	-	-	-	3.23%
EPS (Basic)	10.17	10.71	7.83	10.27	9.16	5.08
EPS (Diluted)	10.17	10.71	7.83	10.27	9.16	5.08
EPS Growth	4.63%	36.78%	-23.76%	12.12%	80.31%	44.73%
Free Cash Flow	179.23	177.58	108.06	132.97	137.76	96.65
Free Cash Flow Growth	0.93%	64.34%	-18.73%	-3.48%	42.53%	67.43%
Free Cash Flow Per Share	-	10.20	6.21	7.64	7.92	5.55
Dividends Per Share	7.000	7.000	4.000	6.000	-	4.000
Dividend Growth	-	75.00%	-33.33%	-	-	166.67%
Gross Margin	95.54%	93.93%	90.24%	93.04%	89.96%	90.12%
Operating Margin	46.86%	47.73%	41.48%	52.13%	47.49%	41.27%
Profit Margin	35.90%	37.61%	33.46%	40.40%	37.33%	31.43%
FCF Margin	36.35%	35.83%	26.53%	30.06%	32.25%	34.38%
EBITDA	259.02	258.05	186.18	251.03	222.89	135.63
EBITDA Margin	52.53%	52.07%	45.70%	56.76%	52.18%	48.25%
EBIT	231.08	236.52	168.97	230.56	202.85	116.02
EBIT Margin	46.86%	47.73%	41.48%	52.13%	47.49%	41.27%
Effective Tax Rate	22.58%	22.34%	22.82%	22.44%	21.53%	21.63%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.